Mirae Asset Global Investments Co., Ltd. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,944,055
+12.3%
387,704
+8.9%
0.02%
+20.0%
Q2 2023$7,076,169
+35.7%
356,051
+16.9%
0.02%
+25.0%
Q1 2023$5,216,376
-6.3%
304,517
+7.1%
0.01%
-14.3%
Q4 2022$5,566,354
+2.2%
284,433
-16.7%
0.01%
-6.7%
Q3 2022$5,448,000
+50.5%
341,396
+29.8%
0.02%
+66.7%
Q2 2022$3,619,000
-52.7%
263,000
-45.5%
0.01%
+12.5%
Q1 2022$7,652,000
+28.7%
482,384
+77.1%
0.01%
-38.5%
Q4 2021$5,947,000
-5.0%
272,404
+30.0%
0.01%
-18.8%
Q3 2021$6,262,000
-14.6%
209,508
+26.5%
0.02%
-20.0%
Q2 2021$7,334,000
+21.5%
165,578
+21.7%
0.02%
-4.8%
Q1 2021$6,038,000
+74.9%
136,078
+116.2%
0.02%
+61.5%
Q4 2020$3,452,000
+207.9%
62,954
+28.3%
0.01%
+116.7%
Q3 2020$1,121,000
+61.1%
49,050
+47.6%
0.01%
+50.0%
Q2 2020$696,000
+154.0%
33,226
+69.2%
0.00%
+100.0%
Q1 2020$274,000
-31.2%
19,635
+12.3%
0.00%0.0%
Q4 2019$398,000
+141.2%
17,488
+23.2%
0.00%
+100.0%
Q3 2019$165,00014,1940.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders